Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Metacrine, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −7 vs. Q2 2021
- Shares held
- 11.1M
- −1.41M (−11.3%) vs. Q2 2021
- Total value
- $37.9M
- −$9.47M (−20.0%) vs. Q2 2021
- New holders
- 4
- 12 more added
- Sold out
- 11
- 9 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 5 | $5.30M |
| Q4 2022 | 29 | $7.29M |
| Q3 2022 | 27 | $3.93M |
| Q2 2022 | 25 | $3.06M |
| Q1 2022 | 31 | $3.83M |
| Q4 2021 | 31 | $2.23M |
| Q3 2021 | 35 | $37.9M |
| Q2 2021 | 42 | $47.4M |
| Q1 2021 | 47 | $82.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Metacrine, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 79 | $0 | 0.00% | −685−89.7% | Reduced |
| Advisor Group Holdings, Inc. | 15 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 995 | $3.00K | 0.00% | −504−33.6% | Reduced |
| Prentice Wealth Management LLC | 750 | $3.00K | 0.00% | +750 | New |
| Royal Bank of Canada | 2,846 | $10.0K | 0.00% | −1,530−35.0% | Reduced |
| Tower Research Capital LLC (TRC) | 4,106 | $14.0K | 0.00% | +1,174+40.0% | Added |
| State Street Corp | 10,605 | $36.0K | 0.00% | 00.0% | Unchanged |
| Edge Wealth Management LLC | 10,600 | $36.0K | 0.01% | 00.0% | Unchanged |
| Wedbush Securities Inc | 12,700 | $44.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 14,303 | $49.0K | 0.00% | −396−2.7% | Reduced |
| Goldman Sachs Group Inc | 15,741 | $54.0K | 0.00% | −9,562−37.8% | Reduced |
| Northern Trust Corp | 16,639 | $57.0K | 0.00% | +4,408+36.0% | Added |
| Group One Trading, L.P. | 18,523 | $64.0K | 0.00% | +18,523 | New |
| Cim Investment Mangement Inc | 19,054 | $65.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 20,312 | $69.0K | 0.00% | −7,942−28.1% | Reduced |
| Belvedere Trading LLC | 29,267 | $102.0K | 0.03% | +29,267 | New |
| Citadel Advisors LLC | 32,429 | $111.0K | 0.00% | +19,719+155.1% | Added |
| Susquehanna International Group, LLP | 48,099 | $165.0K | 0.00% | +48,099 | New |
| Bank of America Corp | 71,304 | $244.0K | 0.00% | +36,532+105.1% | Added |
| New York Life Investments Alternatives | 88,656 | $304.0K | 0.20% | +21,334+31.7% | Added |
| Bridgeway Capital Management, LLC | 94,600 | $324.0K | 0.01% | +15,000+18.8% | Added |
| Two Sigma Investments, LP | 123,659 | $424.0K | 0.00% | +58,836+90.8% | Added |
| Two Sigma Advisers, LP | 136,400 | $468.0K | 0.00% | +87,000+176.1% | Added |
| BlackRock Inc. | 137,919 | $473.0K | 0.00% | +22,795+19.8% | Added |
| Vivo Capital, LLC | 146,426 | $502.0K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 189,548 | $650.0K | 0.00% | −71,872−27.5% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 277,469 | $952.0K | 0.02% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 281,467 | $965.0K | 0.01% | −764,674−73.1% | Reduced |
| Renaissance Technologies LLC | 283,100 | $971.0K | 0.00% | +203,200+254.3% | Added |
| Franklin Resources Inc | 363,600 | $1.25M | 0.00% | −945,457−72.2% | Reduced |
| Vanguard Group Inc | 412,382 | $1.42M | 0.00% | +4,302+1.1% | Added |
| Artal Group S.A. | 924,898 | $3.17M | 0.08% | 00.0% | Unchanged |
| Prosight Management, LP | 1,145,034 | $3.93M | 2.30% | +275,952+31.8% | Added |
| venBio Partners LLC | 3,059,123 | $10.5M | 1.05% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,062,977 | $10.5M | 0.13% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −312,500−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −55,753−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −29,900−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,671−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −14,284−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −13,275−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −11,787−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −883−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −84−100.0% | Sold out |